-
-
Neuromyelitis Optica Spectrum Disorder
-
11th Sep 2017
-
Posted in Australia/New Zealand,Clinical Review Article
- Simon Broadley, Elham Khalili, Saman Heshmat, Laura Clarke
-
-
Anterior cervical discectomy and fusion (ACDF) for degenerative cervical diseases – Six decades on
-
8th Sep 2017
-
Posted in Clinical Review Article
- Jason Yuen and Peter Whitfield
-
-
Epistatus® 10 mg Oromucosal Solution Midazolam – Now Available To Prescribe
-
8th Sep 2017
-
Posted in Industry News,Neurology News
- Press release on behalf of Special Products Ltd
-
-
Mavenclad (Cladribine Tablets) Demonstrates Sustained Disease Control over 4 Years
-
6th Sep 2017
-
Posted in Industry News,Neurology News
- Press release on behalf of Merck
-
-
Real-world data confirms clinical effectiveness of Zebinix®
-
6th Sep 2017
-
Posted in Industry News,Neurology News
- Press release on behalf of Eisai and Bial
-
-
European Commission Grants Approval for Mavenclad (Cladribine Tablets)
-
25th Aug 2017
-
Posted in Industry News,Online First
- First oral short-course treatment for highly active relapsing multiple sclerosis (RMS) now approved in Europe
-
-
MasterClass on the non-oral therapies and new NICE guideline for Parkinson’s
-
24th Aug 2017
-
Posted in Special Feature
- With publication of the new NICE guideline for Parkinson’s, Parkinson’s Academy is holding a series of roadshows exploring the non-oral therapy pathway in detail
-
-
20th Jul 2017
-
Posted in Industry News,Rehabilitation Articles,Special Feature
- ACNR recently partnered with Mediaplanet UK on the 2017 Rehabilitation Campaign in The Guardian newspaper and online
-
-
The Missing Pieces: Identifying the gaps in care and conversations in MS
-
10th Jul 2017
-
Posted in Online First,Special Feature,Sponsored Feature
- Developed and funded by Sanofi Genzyme
-
-
Visual testing in concussion
-
9th Jul 2017
-
Posted in Australia/New Zealand,Clinical Review Article
- Clare L Fraser, Adrian Cohen
